FOXA2 and pancreatic adenocarcinoma: The expressions of FoxA2 and FoxA3 in cholangiocarcinoma were at similar levels with those in colon adenocarcinoma, liver hepatocellular carcinoma, pancreatic adenocarcinoma, rectum adenocarcinoma, and stomach adenocarcinoma (Figure S1B,C).